Prosecution Insights
Last updated: November 20, 2026

Sean M Basquill, USPTO Patent Examiner

Listed by the USPTO as BASQUILL, SEAN M

Tech Center 1600 • Art Units: 1612 1613 1614

This examiner grants 39% of resolved cases

Analysis

BASQUILL, SEAN M is a USPTO patent examiner in tech center 1600 and art unit 1612. The profile records 1077 resolved cases, an allowance rate of 38.7%, an interview lift of 21.1%, and a median time to allowance of 1239 days.

The allowance rate exceeds the interview lift, but both figures support careful assessment of claim presentation and response strategy. The listed companies are Ocular Therapeutix Inc., The Regents of the University of Michigan, and AbbVie Inc. The listed firms are MYERS BIGEL, P.A., Brooks Kushman P.C., and CANTOR COLBURN LLP - UPL LIMITED. The large record and named participants provide context for practitioners evaluating this examiner’s prosecution history.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

38.7%
Allow Rate
-21.3% vs TC avg
1,139
Total Applications
+21.1%
Interview Lift
1239
Avg Prosecution Days
Based on 1077 resolved cases, 2023–2026

Rejection Statute Breakdown

2.2%
§101 Eligibility
8.0%
§102 Novelty
54.3%
§103 Obviousness
19.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18737473 ENHANCED PLANT GROWTH VIA PROCESSED PLANT CELL WALL MATERIAL Non-Final OA The Regents of the University of Michigan
18685853 COMPOSITE NANOPARTICULATE MINERALIZED COLLAGEN GLYCOSAMINOGLYCAN MATERIALS WITH TIME RELEASE ANTI-RESORPTIVE FACTORS Final Rejection The Board of Trustees of the University of Illinois
18611454 OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCESS Non-Final OA Allergan, Inc.
18845312 AGROCHEMICAL EMULSIFIABLE COMPOSITION Final Rejection Nippon Kayaku Kabushiki Kaisha
18535180 NONVIRAL GENE TRANSFER TO THE SUPRACHOROIDAL SPACE Non-Final OA The Johns Hopkins University
17936208 Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response Final Rejection NORTHWESTERN UNIVERSITY
18832440 IONIZABLE LIPIDS, LIPID NANOPARTICLES, AND USES THEREOF Non-Final OA Verily Life Sciences LLC
17772695 SUPPOSITORY CAPSULE Final Rejection R.P. Scherer Technologies, LLC
18359642 OPHTHALMIC TOPICAL CREAM FORMULATIONS AND USES THEREOF Non-Final OA Glaukos Corporation
17788266 HAIR COSMETIC COMPOSITION Non-Final OA KAO CORPORATION
18250114 NANOPARTICLES FOR IMAGING AND THERAPY Non-Final OA University of Connecticut
18839843 POULTICE AND METHOD FOR MANUFACTURING SAME Final Rejection HISAMITSU PHARMACEUTICAL CO., INC.
18840735 COMPOSITIONS AND METHODS FOR LONG LASTING DISINFECTION WITH MIXED SOLVENT SYSTEMS Non-Final OA Specialty Operations France
16969864 METHODS AND COMPOSITIONS FOR PREVENTING, REDUCING OR ERADICATING TOXICITY CAUSED BY ACETAMINOPHEN (APAP) Non-Final OA SINEW PHARMA INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Sean M Basquill's allowance rate?

38.7% of resolved applications examined by Sean M Basquill were allowed (1,077 resolved cases), compared with 40.6% across Art Unit 1612 over the last five years.

Does an interview help with examiner Sean M Basquill?

This examiner's interview lift is +21.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Sean M Basquill take to allow a patent?

Applications allowed by Sean M Basquill took 1,239 days on average from filing to allowance.

Which art unit does examiner Sean M Basquill work in?

Sean M Basquill examines applications in Art Unit 1612 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month